PTGS2 and gastric cancer: Additionally, the combined application of paclitaxel and harmine was found to synergistically inhibit cell proliferation, migration, and invasion in two human gastric cancer cell lines, SGC-7901 and MKN-45, by downregulating COX-2 and MMP-9, suggesting its potential as an effective therapeutic strategy for gastric cancer (116).